Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1509-34-8

Post Buying Request

1509-34-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1509-34-8 Usage

Chemical Properties

White to off-white powder

Uses

L-alloisoleucine is a stereo-isomer of L-isoleucine (I820175) and is produced as a byproduct of isoleucine via transamination.? L-allo-isoleucine has been suggested to induce epithelial β-defensin expression. In addition, L-allo-isoleucine is utilized in the biosynthesis pathway for coronamic acid.

Biochem/physiol Actions

L-allo-Isoleucine may be used in studies on maple syrup urine disease.

Check Digit Verification of cas no

The CAS Registry Mumber 1509-34-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,0 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1509-34:
(6*1)+(5*5)+(4*0)+(3*9)+(2*3)+(1*4)=68
68 % 10 = 8
So 1509-34-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5+/m1/s1

1509-34-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A2214)  L-Alloisoleucine  >95.0%(T)

  • 1509-34-8

  • 200mg

  • 1,180.00CNY

  • Detail
  • TCI America

  • (A2214)  L-Alloisoleucine  >95.0%(T)

  • 1509-34-8

  • 1g

  • 3,900.00CNY

  • Detail

1509-34-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name L-alloisoleucine

1.2 Other means of identification

Product number -
Other names L-allo-Isoleucine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1509-34-8 SDS

1509-34-8Synthetic route

(2S,3R)-(+)-2-Amino-3-methylpent-4-enoic acid
249553-80-8

(2S,3R)-(+)-2-Amino-3-methylpent-4-enoic acid

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
With hydrogen; platinum(IV) oxide In water at 20℃; for 15h; Catalytic hydrogenation;98%
N-[(2S,3R)-2-amino-3-methylpentanoyl]-(1R,2S)-bornane-2,10-sultam
287970-48-3

N-[(2S,3R)-2-amino-3-methylpentanoyl]-(1R,2S)-bornane-2,10-sultam

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
With lithium hydroxide Substitution;92%
Conditions
ConditionsYield
With C13H15NO5V(1-)*C16H36N(1+) In ethanol; waterA 32%
B n/a
With C13H15NO5V(1-)*C16H36N(1+) In ethanol; waterA n/a
B 22%
(2R,3R)-2-bromo-3-methylpentanoic acid
94318-70-4

(2R,3R)-2-bromo-3-methylpentanoic acid

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
bei der Ueberfuehrung in das (Carboxymetyl)-amid, folgenden Aminierung und Hydrolyse;
N-formyl-L-alloisoleucine
911438-83-0

N-formyl-L-alloisoleucine

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
With hydrogen bromide
DL-alloisoleucine
3107-04-8

DL-alloisoleucine

A

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

B

D-alloisoleucine
1509-35-9

D-alloisoleucine

(S)-1-phenyl-ethylamine
2627-86-3

(S)-1-phenyl-ethylamine

2-methyl-4-sec-butylidene-5-oxazolone

2-methyl-4-sec-butylidene-5-oxazolone

A

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

B

L-isoleucine
73-32-5

L-isoleucine

C

D-Isoleucine
319-78-8

D-Isoleucine

D

D-alloisoleucine
1509-35-9

D-alloisoleucine

Conditions
ConditionsYield
Product distribution; Rate constant; multistep reaction;
(2S,3R)-2-Azido-3-methyl-pentanoic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester
106749-12-6

(2S,3R)-2-Azido-3-methyl-pentanoic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester

A

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

B

L-isoleucine
73-32-5

L-isoleucine

C

D-Isoleucine
319-78-8

D-Isoleucine

D

D-alloisoleucine
1509-35-9

D-alloisoleucine

Conditions
ConditionsYield
With titanium tetrakis(benzyl alkoxide); hydrogen; Pd-BaSO4 1.) benzyl alcohol, 130 gradC 2.) EtOH, EtOAc, 1 atm, r.t.; Yield given. Multistep reaction. Title compound not separated from byproducts;
(-)(2S:3R)-2-bromo-3-methyl-valeric acid
21582-41-2

(-)(2S:3R)-2-bromo-3-methyl-valeric acid

ammonium hydroxide

ammonium hydroxide

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
at 37℃;
(R)-3-methylpentanoic acid
16958-25-1

(R)-3-methylpentanoic acid

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 83 percent / SOCl2
2.1: 82 percent / NaH
3.1: NaH(TMS)2 / tetrahydrofuran / 1 h / -78 °C
3.2: 80 percent / 1-chloro-1-nitrosocyclohexane / tetrahydrofuran / 1 h / -78 °C
4.1: 77 percent / Zn powder; aq. HCl / acetic acid / 48 h / 0 °C
5.1: 92 percent / LiOH
View Scheme
N-[3(R)-methylpentanoyl]-(1S,2R)-bornane-2,10-sultam
104651-15-2

N-[3(R)-methylpentanoyl]-(1S,2R)-bornane-2,10-sultam

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: 73 percent / LiOH
2.1: 83 percent / SOCl2
3.1: 82 percent / NaH
4.1: NaH(TMS)2 / tetrahydrofuran / 1 h / -78 °C
4.2: 80 percent / 1-chloro-1-nitrosocyclohexane / tetrahydrofuran / 1 h / -78 °C
5.1: 77 percent / Zn powder; aq. HCl / acetic acid / 48 h / 0 °C
6.1: 92 percent / LiOH
View Scheme
(R)-(-)-3-methylpentanoic acid chloride
287734-99-0

(R)-(-)-3-methylpentanoic acid chloride

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 82 percent / NaH
2.1: NaH(TMS)2 / tetrahydrofuran / 1 h / -78 °C
2.2: 80 percent / 1-chloro-1-nitrosocyclohexane / tetrahydrofuran / 1 h / -78 °C
3.1: 77 percent / Zn powder; aq. HCl / acetic acid / 48 h / 0 °C
4.1: 92 percent / LiOH
View Scheme
N-[(3R)-3-methylpentanoyl]-(1R,2S)-bornane-2,10-sultam
287970-47-2

N-[(3R)-3-methylpentanoyl]-(1R,2S)-bornane-2,10-sultam

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: NaH(TMS)2 / tetrahydrofuran / 1 h / -78 °C
1.2: 80 percent / 1-chloro-1-nitrosocyclohexane / tetrahydrofuran / 1 h / -78 °C
2.1: 77 percent / Zn powder; aq. HCl / acetic acid / 48 h / 0 °C
3.1: 92 percent / LiOH
View Scheme
N-[(2S,3R)-2-(N-hydroxyamino)-3-methylpentanoyl]-(1R,2S)-bornane-2,10-sultam
129505-16-4

N-[(2S,3R)-2-(N-hydroxyamino)-3-methylpentanoyl]-(1R,2S)-bornane-2,10-sultam

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 77 percent / Zn powder; aq. HCl / acetic acid / 48 h / 0 °C
2: 92 percent / LiOH
View Scheme
N-Trifluoroacetylglycine (E/Z)-crotyl ester
338752-33-3

N-Trifluoroacetylglycine (E/Z)-crotyl ester

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: LHMDS; quinidine; Al(OiPr)3 / tetrahydrofuran; hexane / 24 h / 20 °C
1.2: CoCl2*6H2O; KOH / Aspergillus L-acylase ACU06514 / H2O / 24 h / 30 °C / pH 7.0
1.3: KCl; tris-maleate buffer / Crotalus adamanteus venom L-amino acid oxidase; catalase / H2O / 2 h / 30 °C / pH 7.8
2.1: 98 percent / H2 / PtO2 / H2O / 15 h / 20 °C
View Scheme
(R)-3-Methyl-pentanoic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester
106749-13-7

(R)-3-Methyl-pentanoic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 67 percent / LDA, Me3SiCl, NBS
2: 93 percent / NaN3 / dimethylformamide / 60 h / Ambient temperature
3: 1.) Ti(OCH2Ph)4 2.) H2 / 2.) Pd/BaSO4 / 1.) benzyl alcohol, 130 gradC 2.) EtOH, EtOAc, 1 atm, r.t.
View Scheme
(2R,3R)-2-Bromo-3-methyl-pentanoic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester
106749-11-5

(2R,3R)-2-Bromo-3-methyl-pentanoic acid (1R,2S,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 93 percent / NaN3 / dimethylformamide / 60 h / Ambient temperature
2: 1.) Ti(OCH2Ph)4 2.) H2 / 2.) Pd/BaSO4 / 1.) benzyl alcohol, 130 gradC 2.) EtOH, EtOAc, 1 atm, r.t.
View Scheme
DL-alloisoleucine
3107-04-8

DL-alloisoleucine

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
2: absolute ethanol / schwer loesliche Brucin-Salz
3: aqueous HBr
View Scheme
N-formyl-DL-alloisoleucine
4101-35-3, 89810-44-6

N-formyl-DL-alloisoleucine

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: absolute ethanol / schwer loesliche Brucin-Salz
2: aqueous HBr
View Scheme

A

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

B

L-isoleucine
73-32-5

L-isoleucine

C

(2R,3S)-2-acetamido-3-methylpentanoic acid
54831-20-8

(2R,3S)-2-acetamido-3-methylpentanoic acid

Conditions
ConditionsYield
With porcine kidney aminoacylase I In phosphate buffer at 20℃; for 24h; pH=7.0; Title compound not separated from byproducts.;
amphibine-D

amphibine-D

A

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

B

(2S)-2-(dimethylamino)-3-phenylpropanoic acid
17469-89-5

(2S)-2-(dimethylamino)-3-phenylpropanoic acid

Conditions
ConditionsYield
With hydrogenchloride; water at 120℃; for 20h;
7,39-epi-Lagunamide A
1255709-51-3

7,39-epi-Lagunamide A

A

L-alanin
56-41-7

L-alanin

B

N-methylalanine
3913-67-5

N-methylalanine

C

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

D

L-isoleucine
73-32-5

L-isoleucine

F

N-methyl-D-phenylalanine
56564-52-4

N-methyl-D-phenylalanine

Conditions
ConditionsYield
With hydrogenchloride; water at 110℃; for 18h; sealed vial;
lagunamide B
1255709-52-4

lagunamide B

A

L-alanin
56-41-7

L-alanin

B

N-methylalanine
3913-67-5

N-methylalanine

C

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

D

L-isoleucine
73-32-5

L-isoleucine

F

N-methyl-D-phenylalanine
56564-52-4

N-methyl-D-phenylalanine

Conditions
ConditionsYield
With hydrogenchloride; water at 110℃; for 18h; sealed vial;
lagunamide C

lagunamide C

A

L-alanin
56-41-7

L-alanin

B

N-methylalanine
3913-67-5

N-methylalanine

C

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

E

N-methyl-D-phenylalanine
56564-52-4

N-methyl-D-phenylalanine

Conditions
ConditionsYield
With hydrogenchloride; water at 110℃; for 18h;
cordyheptapeptide E
1377420-77-3

cordyheptapeptide E

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
With hydrogenchloride In water at 110℃; for 18h;
Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydroxide / water / Cooling with ice
1.2: pH 2
2.1: penicillin G acylase from Achromobacter sp. CCM 4824; water / 30 °C / pH 7 / Enzymatic reaction
View Scheme
N-PhAc-α-isoleucine

N-PhAc-α-isoleucine

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
With penicillin G acylase from Achromobacter sp. CCM 4824; water at 30℃; pH=7; Reagent/catalyst; Enzymatic reaction; enantioselective reaction;
L-isoleucine
73-32-5

L-isoleucine

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

Conditions
ConditionsYield
With recombinant isomerase DsaE domain from Streptomyces scopuliridis SCSIO ZJ46; recombinant pyridoxal 5′-phosphate (PLP)-linked aminotransferase DsaD domain from Streptomyces scopuliridis SCSIO ZJ46 In aq. phosphate buffer at 30℃; pH=8; Equilibrium constant; Enzymatic reaction;
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane for 2h; 0 deg C to r. t.;99%
With sodium hydroxide In 1,4-dioxane at 20℃; for 2.5h;90%
With sodium hydroxide In 1,4-dioxane at 20℃;
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

ethyl trifluoroacetate,
383-63-1

ethyl trifluoroacetate,

(2S,3R)-3-methyl-2-(2,2,2-trifluoroacetamido)pentanoic acid

(2S,3R)-3-methyl-2-(2,2,2-trifluoroacetamido)pentanoic acid

Conditions
ConditionsYield
With triethylamine In methanol at 20℃; for 24h;99%
phthalic anhydride
85-44-9

phthalic anhydride

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

N-phthaloyl-L-isoleucine
114926-62-4

N-phthaloyl-L-isoleucine

Conditions
ConditionsYield
at 140℃; for 0.166667h;98%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

(-)-ethyl-(R)-3-methyl-2-oxopentanoate
226414-40-0

(-)-ethyl-(R)-3-methyl-2-oxopentanoate

Conditions
ConditionsYield
In hydrogenchloride; chloroform93%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

N-[1-(6-acetyl-7,9-dihydroxy-8,9b-dimethyl-1,3-dioxo-3,9b-dihydro-1H-dibenzofuran-2-ylidene)ethyl]-L-isoleucine

N-[1-(6-acetyl-7,9-dihydroxy-8,9b-dimethyl-1,3-dioxo-3,9b-dihydro-1H-dibenzofuran-2-ylidene)ethyl]-L-isoleucine

Conditions
ConditionsYield
In tetrahydrofuran; ethanol at 80℃; for 4h;85%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

propargyl pentafluorophenyl carbonate
439912-32-0

propargyl pentafluorophenyl carbonate

(2R,3S)-3-Methyl-2-prop-2-ynyloxycarbonylamino-pentanoic acid

(2R,3S)-3-Methyl-2-prop-2-ynyloxycarbonylamino-pentanoic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; N,N-dimethyl-formamide; acetone at -10 - 20℃;83%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

(R)-2-methylbutyric acid
32231-50-8

(R)-2-methylbutyric acid

Conditions
ConditionsYield
With sodium azide; tris-hydrochloride buffer; oxygen; Crotalus adamanteus venom L-amino acid oxidase at 30℃; for 48h; pH=7.2; Oxidation;82%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

(1H-benzo[d][1,2,3]triazol-1-yl)(pyrazin-2-yl)methanone
306990-94-3

(1H-benzo[d][1,2,3]triazol-1-yl)(pyrazin-2-yl)methanone

(pyrazine-2-carbonyl)-L-alloisoleucine

(pyrazine-2-carbonyl)-L-alloisoleucine

Conditions
ConditionsYield
With trialkylamine In water; acetonitrile at 20℃;81%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

4-hydroxy-7-trifluoromethyl-quinoline-3-carboxylic acid ethyl ester
391-02-6

4-hydroxy-7-trifluoromethyl-quinoline-3-carboxylic acid ethyl ester

(2S,3R)-2-({[4-hydroxy-7-(trifluoromethyl)-3-quinolyl]carbonyl}amino)-3-methylpentanoic acid
1370478-24-2

(2S,3R)-2-({[4-hydroxy-7-(trifluoromethyl)-3-quinolyl]carbonyl}amino)-3-methylpentanoic acid

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide for 8h; Reflux;79%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

N-(p-toluenesulfonyl)-alloisoleucine

N-(p-toluenesulfonyl)-alloisoleucine

Conditions
ConditionsYield
Stage #1: D-allo-isoleucine; p-toluenesulfonyl chloride With sodium carbonate In water at 70 - 85℃; for 0.75h;
Stage #2: With hydrogenchloride In water at 20℃; pH=1;
78%
With sodium hydroxide; N-ethyl-N,N-diisopropylamine In acetone at 0 - 20℃;
ethanol
64-17-5

ethanol

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

L-alloisoleucine ethyl ester
44975-82-8

L-alloisoleucine ethyl ester

Conditions
ConditionsYield
With thionyl chloride for 10h; Heating;70%
With hydrogenchloride
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

methyl chloroformate
79-22-1

methyl chloroformate

(2S,3R)-2-(methoxycarbonylamino)-3-methylpentanoic acid
1252601-88-9

(2S,3R)-2-(methoxycarbonylamino)-3-methylpentanoic acid

Conditions
ConditionsYield
With sodium carbonate; sodium hydroxide In 1,4-dioxane at 0 - 20℃;58%
With sodium hydroxide In 1,4-dioxane; water
1-Methyl-4-piperidone
1445-73-4

1-Methyl-4-piperidone

4-(aminomethyl)pyridine
3731-53-1

4-(aminomethyl)pyridine

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

4-fluorobenzyl isocyanide
148890-53-3

4-fluorobenzyl isocyanide

N-(4-fluorobenzyl)-1-methyl-4-(((2S,3R)-3-methyl-1-oxo-1-((pyridin-4-ylmethyl)amino)pentan-2-yl)amino)piperidine-4-carboxamide

N-(4-fluorobenzyl)-1-methyl-4-(((2S,3R)-3-methyl-1-oxo-1-((pyridin-4-ylmethyl)amino)pentan-2-yl)amino)piperidine-4-carboxamide

Conditions
ConditionsYield
In methanol; water at 20℃; Ugi Condensation;51%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

(2S,3R)-2-hydroxy-3-methylpentanoic acid
86630-77-5

(2S,3R)-2-hydroxy-3-methylpentanoic acid

Conditions
ConditionsYield
Stage #1: D-allo-isoleucine With trifluoroacetic acid In 1,4-dioxane; water at 0℃; Inert atmosphere;
Stage #2: With tert.-butylnitrite In 1,4-dioxane; water at 0 - 20℃; for 24h; Inert atmosphere;
50%
With hydrogenchloride; acetic acid; sodium nitrite
With hydrogenchloride; acetic acid; sodium nitrite
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

(2-Hydroxyethyl)isocyanid
32835-59-9

(2-Hydroxyethyl)isocyanid

2-(3,4-dimethoxyphenyl)-ethylamine
120-20-7

2-(3,4-dimethoxyphenyl)-ethylamine

cyclopentanone
120-92-3

cyclopentanone

1-(((2S,3R)-1-((3,4-dimethoxyphenethyl)amino)-3-methyl-1-oxopentan-2-yl)amino)-N-(2-hydroxyethyl)cyclopentanecarboxamide

1-(((2S,3R)-1-((3,4-dimethoxyphenethyl)amino)-3-methyl-1-oxopentan-2-yl)amino)-N-(2-hydroxyethyl)cyclopentanecarboxamide

Conditions
ConditionsYield
In methanol; water at 20℃; Ugi Condensation;33%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide
82911-69-1

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide

C21H21NO4

C21H21NO4

Conditions
ConditionsYield
Stage #1: D-allo-isoleucine With leucine 5-hydroxylase GriE; oxygen; iron(II) sulfate; α-ketoglutaric acid disodium salt; ascorbic acid In aq. phosphate buffer at 20℃; for 5h; pH=7; Enzymatic reaction;
Stage #2: N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide With sodium hydrogencarbonate In water; acetonitrile at 20℃;
Stage #3: In dichloromethane at 20℃; Catalytic behavior; Kinetics; Acidic conditions; regioselective reaction;
23%
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

(-)(2S:3R)-2-bromo-3-methyl-valeric acid
21582-41-2

(-)(2S:3R)-2-bromo-3-methyl-valeric acid

Conditions
ConditionsYield
With nitrosyl bromide
With hydrogen bromide; potassium bromide; sodium nitrite Substitution;
Conditions
ConditionsYield
With sodium hydroxide; benzyl chloroformate
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

(R)-2-methyl-butyraldehyde-(2,4-dinitro-phenylhydrazone)
33204-49-8

(R)-2-methyl-butyraldehyde-(2,4-dinitro-phenylhydrazone)

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

acetic anhydride
108-24-7

acetic anhydride

N-acetyl-L-isoleucine
20257-17-4

N-acetyl-L-isoleucine

Conditions
ConditionsYield
unter Zusatz von wss. NaOH;
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

phenyl isocyanate
103-71-9

phenyl isocyanate

N-phenylcarbamoyl-L-alloisoleucine
102609-71-2

N-phenylcarbamoyl-L-alloisoleucine

Conditions
ConditionsYield
With sodium hydroxide
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

chloroacetyl chloride
79-04-9

chloroacetyl chloride

N-chloroacetyl-L-alloisoleucine
911438-85-2

N-chloroacetyl-L-alloisoleucine

Conditions
ConditionsYield
With sodium hydroxide
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

LS-threo-2-benzenesulfonylamino-3-methyl-valeric acid

LS-threo-2-benzenesulfonylamino-3-methyl-valeric acid

Conditions
ConditionsYield
With sodium hydroxide
D-allo-isoleucine
1509-34-8

D-allo-isoleucine

1-Naphthyl isocyanate
86-84-0

1-Naphthyl isocyanate

N-(naphthyl-(1)-carbamoyl)-L-alloisoleucine
107294-02-0

N-(naphthyl-(1)-carbamoyl)-L-alloisoleucine

Conditions
ConditionsYield
With sodium hydroxide
N-(tert-butyloxycarbonyl) azide
1070-19-5

N-(tert-butyloxycarbonyl) azide

D-allo-isoleucine
1509-34-8

D-allo-isoleucine

1509-34-8Relevant articles and documents

Hirowatari,Walborsky

, p. 604 (1974)

Vanadium(V)-catalyzed epimerization of isoleucine

Krivosudsky, Luká?,Schwendt, Peter,Filo, Juraj

, p. 96 - 99 (2016)

All stereoisomers of isoleucine were transformed to the mixtures of the corresponding epimers by epimerization in alkaline aqueous solution. The catalyst was formed in situ by condensation of salicylaldehyde and isoleucine followed by complexation with va

Versiquinazolines A-K, Fumiquinazoline-Type Alkaloids from the Gorgonian-Derived Fungus Aspergillus versicolor LZD-14-1

Cheng, Zhongbin,Lou, Lanlan,Liu, Dong,Li, Xiaodan,Proksch, Peter,Yin, Sheng,Lin, Wenhan

, p. 2941 - 2952 (2016)

Eleven fumiquinazoline-type alkaloids, namely, versiquinazolines A-K (1-11), along with cottoquinazolines B-D, were isolated from the gorgonian-derived fungus Aspergillus versicolor LZD-14-1. Their structures were determined by extensive analyses of the spectroscopic data (1D and 2D NMR, HRESIMS), in addition to the experimental and calculated ECD data and X-ray single-crystal diffraction analysis for the assignments of the absolute configurations. Versiquinazolines A, B, and F (1, 2, and 6), bearing a methanediamine or an aminomethanol unit and representing a unique subtype of fumiquinazolines, were found from nature for the first time. Possible biogenetic relationships of the versiquinazolines are postulated. In addition, the structures of cottoquinazolines B (12), D (13), and C (14) should be revised to the enantiomers. Compounds 1, 2, 7, and 11 exhibited inhibitory activities against thioredoxin reductase (IC50 values ranging from 12 to 20 μM).

Deciphering the Biosynthetic Origin of L-allo-Isoleucine

Li, Qinglian,Qin, Xiangjing,Liu, Jing,Gui, Chun,Wang, Bo,Li, Jie,Ju, Jianhua

, p. 408 - 415 (2016)

The nonproteinogenic amino acid l-allo-isoleucine (l-allo-Ile) is featured in an assortment of life forms comprised of, but not limited to, bacteria, fungi, plants and mammalian systems including Homo sapiens. Despite its ubiquity and functional importance, the specific origins of this unique amino acid have eluded characterization. In this study, we describe the discovery and characterization of two enzyme pairs consisting of a pyridoxal 5′-phosphate (PLP)-linked aminotransferase and an unprecedented isomerase synergistically responsible for the biosynthesis of l-allo-Ile from l-isoleucine (l-Ile) in natural products. DsaD/DsaE from the desotamide biosynthetic pathway in Streptomyces scopuliridis SCSIO ZJ46, and MfnO/MfnH from the marformycin biosynthetic pathway in Streptomyces drozdowiczii SCSIO 10141 drive l-allo-Ile generation in each respective system. In vivo gene inactivations validated the importance of the DsaD/DsaE pair and MfnO/MfnH pair in l-allo-Ile unit biosynthesis. Inactivation of PLP-linked aminotransferases DsaD and MfnO led to significantly diminished desotamide and marformycin titers, respectively. Additionally, inactivation of the isomerase genes dsaE and mfnH completely abolished production of all l-allo-Ile-containing metabolites in both biosynthetic pathways. Notably, in vitro biochemical assays revealed that DsaD/DsaE and MfnO/MfnH each catalyze a bidirectional reaction between l-allo-Ile and l-Ile. Site-directed mutagenesis experiments revealed that the enzymatic reaction involves a PLP-linked ketimine intermediate and uses an arginine residue from the C-terminus of each isomerase to epimerize the amino acid β-position. Consequently, these data provide important new insight into the origins of l-allo-Ile in natural products with medicinal potential and illuminate new possibilities for biotool development.

Structural relationships in crystals accommodating different stereoisomers of 2-amino-3-methylpentanoic acid

Dalhus, Bjoorn,Goerbitz, Carl Henrik

, p. 720 - 727 (2000)

A reinvestigation of the crystal structure of the 1:1 mixture of the two racemates DL-isoleucine and DL-allo-isoleucine, with a detailed analysis of interatomic distances between alternative side-chain positions, reveals a systematic distribution of the four stereoisomers in this crystal. Two different molecular chains exist in the crystal and each such chain accommodates a single diastereomeric pair only (L-isoleucine:D-allo-isoleucine or D-isoleucine:L-allo-isoleucine). The crystal is built up by a stacking of such chains in two dimensions and three different packing modes for the two types of chains are discussed. Crystallization experiments of the two individual racemates in the 1:1 mixture of DL-isoleucine:DL-allo-isoleucine have been undertaken. The structure of the racemate DL-isoleucine is presented. The molecular arrangements in this racemate and the 1:1 DL-isoleucine:DL-allo-isoleucine mixture are closely related. Furthermore, the spontaneous resolution of enantiomers upon crystallization of the other racemate, DL-allo-isoleucine, is rationalized on the basis of the aforementioned analysis of interatomic distances in the 1:1 DL-isoleucine:DL-allo-isoleucine complex. Structural data for a new L-isoleucine: D-allo-isoleucine complex are also given.

Jamaicensamide A, a Peptide Containing β-Amino-α-keto and Thiazole-Homologated η-Amino Acid Residues from the Sponge Plakina jamaicensis

Jamison, Matthew T.,Molinski, Tadeusz F.

, p. 2243 - 2249 (2016)

A new cyclic peptide, jamaicensamide A, composed of six amino acids, including a thiazole-homologated amino acid, was isolated from the Bahamian sponge Plakina jamaicensis, along with known compounds bitungolide A and franklinolide A. The structure of the title peptide was solved by integrated analysis of MS, 1D and 2D NMR data, oxidation-hydrolyses to α-amino acids, and their stereodetermination by Marfey's method. The close structural resemblance of Western Atlantic-derived jamaicensamide A to known Western Pacific-derived peptides of lithistid sponges in the genus Theonella and Discodermia suggests a common origin: the symbiotic bacterium Entotheonella sp., a so-called "talented producer" responsible for biosynthesis of most Theonella-associated peptides. Similar natural products from sponges of disparate genera evince the likelihood that these invertebrates harbor the same or a very similar symbiont.

Rational engineering ofAcinetobacter tandoiiglutamate dehydrogenase for asymmetric synthesis ofl-homoalanine through biocatalytic cascades

Diao, Shiqing,Jiang, Shuiqin,Liu, Yan,Sun, Yangyang,Wang, Hualei,Wang, Liuzhu,Wei, Dongzhi

, p. 4208 - 4215 (2021/06/30)

l-Homoalanine, a useful building block for the synthesis of several chiral drugs, is generally synthesized through biocascades using natural amino acids as cheap starting reactants. However, the addition of expensive external cofactors and the low efficiency of leucine dehydrogenases towards the intermediate 2-ketobutyric acid are two major challenges in industrial applications. Herein, a dual cofactor-dependent glutamate dehydrogenase fromAcinetobacter tandoii(AtGluDH) was identified to help make full use of the intracellular pool of cofactors when using whole-cell catalysis. Through reconstruction of the hydrophobic network between the enzyme and the terminal methyl group of the substrate 2-ketobutyric acid, the strict substrate specificity ofAtGluDH towards α-ketoglutarate was successfully changed, and the activity obtained by the most effective mutant (K76L/T180C) was 17.2 times higher than that of the wild-type protein. A three-enzyme co-expression system was successfully constructed in order to help release the mass transfer restriction. Using 1 Ml-threonine, which is close to the solubility limit, we obtained a 99.9% yield ofl-homoalanine in only 3.5 h without adding external coenzymes to the cascade, giving 99.9% ee and a 29.2 g L?1h?1space-time yield. Additionally, the activities of the engineeredAtGluDH towards some other hydrophobic amino acids were also improved to 1.1-11.2 fold. Therefore, the engineering design of some dual cofactor-dependent GluDHs could not only eliminate the low catalytic activity of unnatural substrates but also enhance the cofactor utilization efficiency of these enzymes in industrial applications.

Asymmetric β-Methylation of l- and d-α-Amino Acids by a Self-Contained Enzyme Cascade

Liao, Cangsong,Seebeck, Florian P.

supporting information, p. 7184 - 7187 (2020/03/17)

This report describes a modular enzyme-catalyzed cascade reaction that transforms l- or d-α-amino acids to β-methyl-α-amino acids. In this process an α-amino acid transaminase, an α-keto acid methyltransferase, and a halide methyltransferase cooperate in two orthogonal reaction cycles that mediate product formation and regeneration of the cofactor pyridoxal-5′-phosphate and the co-substrate S-adenosylmethionine. The only stoichiometric reagents consumed in this process are the unprotected l- or d-α-amino acid and methyl iodide.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1509-34-8